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Subtilisin-like serine peptidases (subtilases) play important roles in the life cycle of many
organisms, including the protozoan parasites that are the causative agent of malaria,
Plasmodium spp. As with other peptidases, subtilase proteolytic activity has to be tightly
regulated in order to prevent potentially deleterious uncontrolled protein degradation.
Maturation of most subtilases requires the presence of an N-terminal propeptide that
facilitates folding of the catalytic domain. Following its proteolytic cleavage, the propep-
tide acts as a transient, tightly bound inhibitor until its eventual complete removal to gen-
erate active protease. Here we report the identiﬁcation of a stand-alone malaria parasite
propeptide-like protein, called SUB1-ProM, encoded by a conserved gene that lies in a
highly syntenic locus adjacent to three of the four subtilisin-like genes in the Plasmodium
genome. Template-based modelling and ab initio structure prediction showed that the
SUB1-ProM core structure is most similar to the X-ray crystal structure of the propeptide
of SUB1, an essential parasite subtilase that is discharged into the parasitophorous
vacuole (PV) to trigger parasite release (egress) from infected host cells. Recombinant
Plasmodium falciparum SUB1-ProM was found to be a fast-binding, potent inhibitor of P.
falciparum SUB1, but not of the only other essential blood-stage parasite subtilase,
SUB2, or of other proteases examined. Mass-spectrometry and immunoﬂuorescence
showed that SUB1-ProM is expressed in the PV of blood stage P. falciparum, where it
may act as an endogenous inhibitor to regulate SUB1 activity in the parasite.
Introduction
Proteolytic enzymes perform numerous regulatory and degradative roles across the kingdoms of life.
A universal requirement for the expression of these potentially highly damaging enzymes in all organ-
isms is tight control of their proteolytic activity in time and space. This is achieved in a multitude of
ways, ranging from the stringent regulation of protease maturation through to the strategic expression
of endogenous regulatory molecules that act in trans to positively or negatively modulate protease
activity. Members of the second largest family of serine peptidases, the subtilisin-like serine proteases
(clan SB family S8, or subtilases) are typically expressed as enzymatically inactive zymogens which, in
the case of secreted subtilases, comprise a single polypeptide that minimally possess a (usually)
N-terminal prodomain, or propeptide, appended to the catalytic domain. The propeptide acts as an
‘intramolecular chaperone’, being essential for correct folding of the catalytic domain. In addition,
maturation of the protease is generally associated with proteolytic cleavage of the propeptide segment,
which continues to act as a temporary high-afﬁnity bound inhibitor until its complete removal by
further proteolysis and/or a change in environmental conditions. Removal of the propeptide generates
the free, enzymatically active protease (for an excellent review of subtilisin maturation, see [1]).
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Subtilisin propeptides are usually therefore potent, competitive inhibitors of their cognate enzymes (with Ki
values typically in the low nM range) and in some instances have also been shown to inhibit heterologous
subtilisins too (e.g. [2]).
In acknowledgement of the inhibitory potency of subtilisin propeptides, the MEROPS database of peptidases
and peptidase inhibitors (see https://www.ebi.ac.uk/merops/) includes several bona ﬁde subtilisin propeptides
within its I9 family (clan JC) of inhibitors. The I9 family also includes three well-characterised proteins that,
despite lacking signiﬁcant sequence similarity, resemble ‘stand-alone’ subtilisin propeptides, being small gene
products in their own right that closely mimic the propeptide fold but that are not derived from larger enzyme
precursors. All three proteins (Pleurotus ostreatus peptidase A inhibitor 1, Saccharomyces cerevisiae peptidase B
inhibitor and Arabidopsis thaliana subtilisin propeptide like inhibitor 1), display typically potent inhibition of
one or more subtilisin-like proteases [3–6]. A further recently characterised example of a subtilisin propeptide-
like mimic is microneme protein 5 (TgMIC5; [7]) of the parasitic protist Toxoplasma gondii, which regulates
the activity of a subtilase that ‘trims’ surface proteins involved in motility of the parasite [8]. The existence of
such stand-alone propeptide-like proteins may reﬂect a process of convergent evolution [9] in which the subtili-
sin propeptide fold has been adopted to carry out regulatory protease inhibitory functions independent of any
chaperone activity.
Malaria is caused by an obligate intracellular protozoan parasite that shares its life cycle between an
Anopheline mosquito vector and a vertebrate host. In the latter, the parasite undergoes a transient ampliﬁcation
step in the liver before initiating its asexual blood-stage life cycle, which comprises repeated cycles of invasion
into red blood cells (RBC), intracellular replication to form a multinucleated form called a schizont, then for-
mation and egress of invasive merozoites with concomitant lytic destruction of the host RBC. The malarial
genome encodes just four secreted subtilisin-like proteins, each of which has orthologues in all Plasmodium
species examined. Three of these (termed SUB1, SUB2 and SUB3) are expressed as enzymatically active pro-
teases [10–16], whereas the fourth (PIMMS2 or SOPT) has unusual features including a non-canonical catalytic
triad that suggest that it likely lacks enzyme activity [17,18]. The best-characterised member of the Plasmodium
subtilase family is SUB1, which is initially stored in a set of secretory organelles of the developing merozoite
called exonemes [19]. Minutes before egress of mature merozoites from the infected RBC, SUB1 is discharged
under the control of a cGMP-dependent signal into the lumen of the parasitophorous vacuole (PV), the
intraerythrocytic compartment within which the parasite replicates. There, SUB1 precisely cleaves a number
of resident soluble and merozoite surface proteins [19–21]. Gene disruption and mutagenesis studies have
revealed essential roles for Plasmodium falciparum SUB1 (PfSUB1) and its protein substrates in asexual
blood-stage parasite egress [22–24]. SUB1 is also required for egress of the liver stage merozoites that initiate the
blood-stage lifecycle [25,26], identifying this subtilase as an important player in parasite replication and virulence.
Here we identify a stand-alone subtilisin propeptide-like protein that is probably expressed in the PV of
asexual blood stages of the malaria parasite and that is a potent and selective inhibitor of SUB1.
Materials and methods
Antibodies and reagents
Rabbit polyclonal antibodies speciﬁc for the P. falciparum merozoite surface protein MSP4 (MRA-319, kind
gifts of Ross Coppel, Monash University, Australia) were obtained through BEI Resources, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, U.S.A., and used in
immunoﬂuorescence analysis (IFA) at a dilution of 1:200. A rabbit polyclonal antiserum against SERA5 has
been described previously [27], and was used at a 1 : 2000 dilution. Monoclonal antibodies X509 [28] and 89.1
[29], speciﬁc for P. falciparum MSP1, have also been previously described. For generation of antibodies to
SUB1-ProM, ﬁve CD1 mice were immunised with puriﬁed recombinant glutathione S-transferase
(GST)-SUB1-ProM (50 mg protein per immunisation), boosting at days 14, 28 and 56, with a terminal bleed
on day 87. Serum was collected after storage of the blood overnight at 4°C. Reactivity of individual antisera
was determined by IFA of ﬁxed P. falciparum schizonts. Four sera showing reactivity were pooled in equal
proportions and subsequently used in IFA at a ﬁnal dilution of 1 : 50. Production and puriﬁcation of chymotrypsin-
treated recombinant P. falciparum SUB1 (rPfSUB1) and design of the ﬂuorogenic dodecapeptide PfSUB1 substrate
SERA4st1F-6R12, based on a PfSUB1 cleavage site within the endogenous protein substrate SERA4, have been
described previously [14,30]. Rapamycin and subtilisin Carlsberg (SUBC, Bacillus licheniformis) were from Sigma,
and pronase (from Streptomyces griseus) was from Boehringer.
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Parasites and IFA
Wild type P. falciparum clone 3D7 and the transgenic P. falciparum clones SUB1HA3:loxP [24] and B11 [31]
were routinely maintained and synchronised using standard methods [32] in cultures containing human ery-
throcytes at a 2.5% haematocrit in RPMI 1640 medium containing 0.5% (w/v) Albumax II (Life Technologies,
U.K.) in an atmosphere of 5% O2, 5% CO2, and 90% N2. For analysis by IFA, mature, Percoll-enriched schi-
zonts were resuspended with uninfected erythrocytes at 50% haematocrit to a ﬁnal parasitaemia of ∼1%. Thin
ﬁlms were air dried then ﬁxed at room temperature in 4% paraformaldehyde/0.0075% glutaraldehyde in
phosphate-buffered saline (PBS) for 30 min. Fixative was exchanged for 0.1% Triton X-100 in PBS for 10 min
to permeabilize the cells, then slides were blocked overnight in 3% (w/v) BSA in PBS at 4°C. Blocked slides
were rinsed in PBS for 5 min, then excess PBS removed and discrete regions drawn on to the smear with a
liquid blocker pen (Thermo Fisher Scientiﬁc). These regions were incubated with primary antibodies overnight
at 4°C, then washed three times in PBS with shaking, followed by incubation for 2 h in the dark with combina-
tions of secondary antibodies. These were as appropriate: goat anti-mouse Alexa Fluor 488 (A-11029; Thermo
Fisher Scientiﬁc; used at 1 : 1000); and goat anti-rabbit Alexa Fluor 594 (A-11037; Thermo Fisher Scientiﬁc;
used at 1 : 1000). Slides were washed three times in PBS and sealed under coverslips with Fluoroshield mount-
ing ﬂuid containing 4,6-diamidino-2-phenylindol (DAPI) for nuclear staining (Sigma). Samples were imaged
using a Zeiss Axiovision wide ﬁeld ﬂuorescence microscope and Volocity deconvolution software.
Bioinformatics analysis
The Plasmodium genomic resource PlasmoDB (http://plasmodb.org/plasmo/) was used to identify and select
PF3D7_0507400 (PfSUB1-ProM) orthologues from the available synteny list: these were PGSY75_0507400,
P. gaboni; PFIT_0507400, P. falciparum; PRCDC_0506600, P. reichenowi; PCHAS_110670, P. chabaudi
chabaudi; PY17X_1108100, P. yoelii; PBANCA_1107000, P. berghei; PKNH_1026200, P. knowlesi;
PKNOH_S07464200, P. knowlesi; PVX_097930, P. vivax; PcyM_1026600, P. cynomolgi; PCYB_103420,
P. cynomolgi; PGAL8A_00028500, P. gallinaceum; PRELSG_1025100, P. relictum; PocGH01_10034100, P. ovale
curtisi. The Clustal Omega server (https://www.ebi.ac.uk/Tools/msa/clustalo/, EMBL-EBI Services) was used
to align all the predicted primary amino acid sequences and to provide an associated identity matrix. The
resulting alignment was fed to the utility rendering program ESPrit3 (http://espript.ibcp.fr/ESPript/ESPript/)
together with the PDB ﬁle from the Modeller SUB1-ProM output model in order to visualise secondary
structure information from the model together with the alignment sequences.
Protein structure prediction
Modeller v9.20 (https://salilab.org/modeller/release.html) was used in conjunction with the UCL psipred Proﬁle
Based Fold Recognition routine pGenTHREADER (http://bioinf.cs.ucl.ac.uk/psipred/) to generate a predicted
structure of SUB1-ProM based on the best-identiﬁed template (PDB ID: 4LVN). The model with the lowest
molpdf score and the best geometry from the Ramachandran plot statistics (preferred 91%, allowed 2.26%,
outlier 6.74%) was chosen out of the ﬁve models generated by Modeller. I-Tasser (Iterative Threading
ASSEmbly Reﬁnement; https://zhanglab.ccmb.med.umich.edu/I-TASSER/), which uses a meta-threading
method (Local Meta-Threader Server) for template-based protein structure prediction, was also used to gener-
ate a SUB1-ProM model, the co-ordinates of which were fed to the PDBeFold server (www.ebi.ac.uk/msd-srv/
ssm/) to search for a similar fold in the PDB. The same strategies were used to model the Plasmodium yoelii
orthologue PY17X_1108100.
The Robetta protein structure prediction server (http://robetta.bakerlab.org) and the QUARK server (https://
zhanglab.ccmb.med.umich.edu/QUARK/) were used for ab initio modelling. Visualisation, manipulation and
images of the models were made within the PyMOL Open-Source Molecular Graphic System (https://pymol.
org/2/).
Recombinant expression of GST-rSUB1-ProM and puriﬁcation of rSUB1-ProM
A synthetic gene corresponding to residues 28–153 of PF3D7_0507400 (SUB1-ProM) was cloned into the
GST-tag expression vector pGEX-6P-1 (GE Healthcare) with an added human rhinovirus 3C protease cleavage
site (kindly provided by Andrew Osborne, University College London) and transformed into BL21(R2) E. coli
cells cultured in the presence of ampicillin (100 mg/ml) and chloramphenicol (34 mg/ml). A freshly picked
colony was used to grow a starter culture from which 1 ml was seeded into 1 litre Luria broth supplemented
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with ampicillin (100 mg/ml) in a 5 litre ﬂask. Protein production was induced with 1 mM IPTG when the
OD600 of the culture reached 0.4–0.6. The cells were harvested by centrifugation after overnight growth at 37°
C. Pellets were frozen, resuspended in cold PBS (50 ml PBS per ml culture), then lysed by sonication on ice in
15 s bursts and the lysate clariﬁed by centrifugation at 12 000×g for 30 min at 4°C. The supernatant was supple-
mented with Glutathione Sepharose 4B resin (GE Healthcare; 1 ml 50% slurry per litre culture). The binding
was allowed at 4°C on a rolling platform overnight. The beads were washed in phosphate-buffered saline (PBS)
and the protein eluted in two successive 10 min incubation steps with 50 mM Tris–HCl, 10 mM reduced gluta-
thione, pH 8.0. Proteolytic removal of the GST fusion protein partner was achieved by adding 200 mg
PreScission protease (GE Healthcare) per 10 mg GST-rSUB1-ProM fusion protein. The protein mixture was
transferred to a 7 kDa cut-off dialysis cassette and exchanged against 3 litres of 50 mM Tris–HCl, 150 mM
NaCl, 1 mM EDTA, 1 mM DTT pH 7.0, for 2–4 h at 4°C, when the buffer was replaced and dialysis continued
overnight. For each 10 ml of protein, 1 mini cOmplete protease inhibitor tablet (Roche) was added and the
protein sample clariﬁed by passage through a 0.22 mm ﬁlter. The protein was concentrated on a Centricon
70-plus ultraﬁltration cartridge (10 kDa cut-off, Millipore) and ﬁnally polished by chromatography on a
HiLoad Superdex 200 (26/60) prep grade size-exclusion column equilibrated in 20 mM HEPES, 150 mM NaCl,
pH 7.4. The puriﬁed rSUB1-ProM eluted as a single peak which migrated as a doublet on reducing SDS–PAGE
at the expected apparent molecular mass of ∼14 kDa. Protein gel slices were submitted for N-terminal sequen-
cing (Alta Bioscience, U.K.) and ﬁve cycles of Edman degradation used to identify the N-terminal ﬁve amino
acid residues of the smaller SUB1-ProM product.
CD measurements
Far-UV circular dichroism (CD) spectra (200–260 nm) of puriﬁed rSUB1-ProM were recorded on a Jasco J-815
spectropolarimeter ﬁtted with a cell holder, temperature controlled by a CDF-426S Peltier unit. Measurements
were performed at 20°C at a protein concentration of 0.15 mg/ml in 20 mM HEPES pH 7.4, 35 mM NaCl, 2%
glycerol, using fused silica cuvettes with 1 mm path length (Hellma, Jena, Germany). Spectra were recorded
with 0.2 nm resolution and baseline corrected by subtraction of the appropriate buffer spectrum. CD intensities
are presented as the mean residue CD extinction coefﬁcient (Δεmrw) calculated as:
D1mrw ¼ S mrw32980  cmg=ml  L
where S is the signal in millidegrees, mrw is the mean residue weight (molecular mass divided by the number
of residues), cmg/ml is the concentration in mg/ml, and L is the pathlength (in cm). Secondary structure content
was estimated using previously described methods [33].
Protease inhibition assays and kinetic analysis
Assays of the proteolytic activity of rPfSUB1, subtilisin Carlsberg (SUBC, bacillus licheniformis; Sigma) and
pronase (from Streptomyces griseus; Boehringer) were based on cleavage of the ﬂuorogenic peptide substrate
SERA4st1F-6R12 (Ac-CKITAQDDEESC-OH labelled on both cysteine sidechains with tetramethylrhodamine)
[30]. The substrate exhibits low ﬂuorescence in its intact state due to non-covalent, concentration-dependent
dimerisation of the rhodamine moieties. Cleavage at any position within the peptide backbone allows dissoci-
ation of the rhodamine dimer, leading to a ﬂuorescence increase [34]. Chymotrypsin-treated rPfSUB1 was
stored as a 228 U/ml stock in 20 mM Tris–HCl pH 8.2, 150 mM NaCl, 10% glycerol. Puriﬁed rSUB1-ProM
was stored as a stock solution (49.5 mM) in 20 mM HEPES, pH 7.4, 150 mM NaCl, from which it was diluted
to ﬁnal concentrations in the 7.81–250 nM range in the ﬁnal reactions. For simple inhibition assays, PfSUB1
(0.045 units in 100 ml 25 mM Tris–HCl pH 8.2, 25 mM CHAPS, 12 mM CaCl2), or subtilisin Carlsberg
(50 mg/ml in 100 ml 20 mM HEPES pH 7.4, 10 mM CaCl2) or pronase (0.1 mg/ml in 100 ml 20 mM Tris–HCl
pH 8.2, 150 mM NaCl) in wells of white 96-well microtitre plates (Nunc) was pre-incubated with 0.4 mM
rSUB1-ProM for 5 min then substrate (0.1 mM ﬁnal) added and ﬂuorescence increase continuously monitored
with time at 21°C using a SpectraMax M5e plate reader with the SoftMax Pro 6.3 software as described previ-
ously [30], with readings taken every 3 to 5 min for 25–60 min using excitation and emission values of 552 nm
and 580 nm, respectively. All experiments were performed in duplicate.
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For determination of the apparent tight-binding inhibition constant, Ki(app), for inhibition of rPfSUB1 by
rSUB1-ProM, the hydrolysis of SERA4st1F-6R12 by rPfSUB1 in the absence of SUB1-ProM was ﬁrst moni-
tored, followed by the addition of SUB1-ProM with negligible dilution of the reaction at a range of ﬁnal con-
centrations (7.81 nM, 15.62 nM, 31.25 nM, 62.5 nM, 125 nM and 250 nM), thereafter allowing the rate of the
reaction to reach a new steady state. The concentration of SERA4st1F-6R12 used was well below its Km, under
which conditions Ki(app)∼ Ki [35]. In the absence of inhibitor, the hydrolysis rate was linear over the selected
time period and no more than 10% of the total available substrate was hydrolysed.
SUB2-mediated MSP1 shedding assay
To evaluate the effects of rSUB1-ProM on PfSUB2-mediated shedding of the merozoite surface protein MSP1,
highly mature synchronous P. falciparum 3D7 schizonts were washed and resuspended in protein-free RPMI
1640 medium with no additions, or EDTA (10 mM), or puriﬁed rSUB1-ProM (80 mg/ml), then incubated at
37°C for 30 min to allow egress to occur naturally. Residual schizonts were pelleted by centrifugation and clari-
ﬁed supernatant samples analysed by Western blot as described previously [10,22], probing with the mouse
monoclonal antibody 89.1 (diluted 1 : 5000), which recognises an epitope within the N-terminal segment of
MSP1, or the human monoclonal antibody X509 (1 : 1000), which recognises an epitope close to the
C-terminal region of MSP1.
Generation of transgenic P. falciparum
A PF3D7_0507400 seed (nucleotides 298–317) was cloned into a dual Cas9-seed plasmid (pDC2-cam-Cas9-
U6-hDHFR; kindly provided by Marcus Lee, Sanger Institute, U.K.) using InFusion cloning (Takara Clontech)
with complementary seed primers (50-AAGTATATAATATTGTCAAAACTTATGAATTCTTGGTTTTAG-
32#AGCTAGAA-30 and 50-TTCTAGCTCTAAAACCAAGAATTCATAAGTTTTGACAATATTATATACTT-30).
For the donor repair plasmid, PF3D7_0507400 nucleotides 52 to 320 were used as the 50 homology region.
Silent mutations were introduced at nucleotides 303, 306, 312 and 315 (within the seed sequence). Sequence
encompassing nucleotides 321 to the end of the ORF were re-codonised. The P. falciparum SERA2 intron con-
taining an internal loxP site (loxPint) [36] was inserted after base 381. A stop codon, a second loxP site and 30
homology region (900 bp of P. falciparum sequence beyond the PF3D7_0507400 stop codon) were placed
immediately following the re-codonised sequence. The truncated SUB1-ProM protein product predicted
to be expressed from the excised locus would end at residue 127 and be terminated after a further eight
residues coded by intron sequence. For introduction of the plasmids into P. falciparum, 10 mg donor plasmid
was linearised using PstI (Thermo Fisher Scientiﬁc) and transfected by electroporation along with 10 mg
circular Cas9 seed plasmid into the P. falciparum 3D7 DiCre-expressing B11 clone, as described previously
[31]. Cloned lines from two independent transfection experiments were generated by limiting dilution. Correct
splicing of the loxPint intron in the parasite clones was conﬁrmed by nucleotide sequencing of gel-puriﬁed
RT-PCR product.
Growth rate quantiﬁcation of transgenic P. falciparum
Ring-stage parasites of four transgenic clones from two independent transfections (as well as a ﬁfth clone that
had not sustained modiﬁcation of the PF3D7_0507400 locus and so acted as a wild-type control for PCR
purposes) were treated for 4 h by incubation in medium containing 100 nM rapamycin in 0.1% v/v DMSO, or
DMSO only (vehicle only control) for 4 h, after which time the drug (or solvent) was washed out. At 24 h,
cultures were sampled for diagnostic PCR to conﬁrm modiﬁcations to the locus. At 48 h, parasitaemia values
were calculated and normalised to 0.1% and/or 1%. After a further 48 h (0.1% and 1% starting parasitaemia
cultures) and again at 96 h (0.1% starting parasitaemia cultures), cultures were sampled, stained with Vybrant
Green (Thermo Fisher Scientiﬁc), and DNA-positive events quantiﬁed by ﬂow cytometry (BD Aria Fusion).
Results
Identiﬁcation of a conserved Plasmodium gene encoding a subtilisin
propeptide-like protein
P. falciparum gene PF3D7_0507400 was initially highlighted as part of a genome-wide bioinformatic screen
for blood-stage parasite genes that have a transcriptional proﬁle similar to that of the invasion-associated
merozoite protein apical membrane antigen-1 (AMA1) [37], and that contain a predicted signal sequence or
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transmembrane domain. PF3D7_0507400 comprises a single exon on chromosome 5 lying between the SUB1
gene (PF3D7_0507500) and the PIMMS2/SOPT gene (PF3D7_0507300) (Figure 1). This is followed in turn by
the SUB3 gene (PF3D7_0507200), with all four genes being transcribed in the same direction. Annotated in
PlasmoDB (http://plasmodb.org/plasmo/) as a conserved gene of unknown function, PF3D7_0507400 has clear
orthologues at highly syntenic locations in all Plasmodium genomes examined.
PF3D7_0507400 encodes a 153-residue protein with a predicted 27-residue secretory signal peptide (SignalP
4.1; [38]) and a total predicted molecular mass of ∼17.9 kDa. Alignment of the predicted protein products of
several of these orthologues (Figure 2a and Supplementary Figure S1) reveals conservation of several primary
structural features, including the signal peptide. The orthologues display no predicted transmembrane domain
or predicted glycosyl phosphatidylinositol anchor signal and share particularly high identity within the
C-terminal region of each protein. BLAST analysis of the non-redundant protein databases with the predicted
PF3D7_0507400 primary sequence revealed no signiﬁcant similarities beyond the Plasmodium orthologues.
However, submission of the predicted mature P. falciparum protein sequence (Gln28–Leu153) to protein fold
prediction using pGenTHREADER [39] in combination with Modeller v9.20 (https://salilab.org/modeller/) [40]
identiﬁed in each case the X-ray crystal structures of PfSUB1 (PDB ID: 4LVN) [14] and P. vivax SUB1
(PvSUB1; PDB ID: 4TR2) [41] as the best templates. Examination using the pGenTHREADER/Modeller pro-
grammes of even the most divergent orthologue relative to the P. falciparum 3D7 gene (P. yoelii 17X
PY17X_1108100; 28.67% identity; Supplementary Figure S1), again identiﬁed the PfSUB1 structure as the best
structural template. Predicted structural homology was restricted to the propeptides of both Plasmodium subti-
lisins (called Prodp9 in the case of PfSUB1; [14]). Similar to previously determined family S8 bacterial
and mammalian subtilisin propeptide structures (e.g. [42–44]) as well as the P. falciparum SUB2 (PfSUB2) pro-
peptide [45] and the stand-alone propeptide mimic TgMIC5 (PDB ID: 2LU2) [7], the core of both SUB1
propeptides comprises two antiparallel alpha helical elements, one of which is slightly kinked, packed against a
four-stranded antiparallel beta sheet to produce an overall compact βαβ–βαβ topology (Figure 2b and
Supplementary Figure S2).
To further investigate potential structural features of the PF3D7_0507400 and PY17X_1108100 gene pro-
ducts, the sequences were submitted to analysis using I-Tasser (Iterative Threading ASSEmbly Reﬁnement;
https://zhanglab.ccmb.med.umich.edu/I-TASSER/) which uses a meta-threading method for template-based
protein structure prediction. The resulting PF3D7_0507400 I-Tasser model showed a conﬁdence score of −3.49
(C-scores ranging from −5 to 2 for best quality models) with an estimated TM-score of 0.33 ± 0.11.
Co-ordinates of the model were fed into the PDBeFold server (http://www.ebi.ac.uk/msd-srv/ssm/) to search for
a similar fold in the PDB, identifying the PfSUB1 propeptide and T. gondii MIC5 amongst the top three solu-
tions. Superimposition of the Modeller and I-Tasser PF3D7_0507400 models with the PfSUB1 propeptide
structure resulted in RMSD values of 0.4 Å and 1.07 Å, respectively (Figure 2b). The same strategies were used
to model the gene product of PY17X_1108100, once again identifying the PfSUB1 prodomain as the best
template (Supplementary Figure S2).
As a ﬁnal, non-template-based approach to investigating the predicted structure of PF3D7_0507400, the
sequence was analysed using two ab initio modelling servers. Submission to the Robetta protein structure pre-
diction server (http://robetta.bakerlab.org), which uses the Rosetta software package for de novo prediction,
Figure 1. The P. falciparum PF3D7_0507400 gene is ﬂanked by three genes encoding subtilisin-like proteins and is located in a
region of high synteny across the Plasmodium genus.Architecture of P. falciparum 3D7 chromosome 5 in the vicinity of the
PF3D7_0507400 gene. The SUB1, PIMMS2/SOPT and SUB3 genes (blue) ﬂank the PF3D7_0507400 locus (red). Arrows
denote the direction of transcription. The entire locus is highly syntenic across all sequenced Plasmodium genomes (see
PlasmoDB; http://plasmodb.org/plasmo/).
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generated a model with a conﬁdence score of 0.34 (1 being the best possible score) corresponding to the
average pairwise TM-score (a measure of global fold similarity) of the top 10 Rosetta models. The QUARK
server (https://zhanglab.ccmb.med.umich.edu/QUARK/) was similarly used as an additional ab initio protein
structure prediction method due to its excellent performance in the CASP9 and CASP10 (Critical Assessment
of Structure Prediction) experiments (Protein Structure Prediction Center; http://predictioncenter.org/). The
co-ordinates of the QUARK model were fed into the PDBeFold server (www.ebi.ac.uk/msd-srv/ssm/) to search
for a similar fold in the PDB; the PfSUB1 propeptide structure (4LVN) was present amongst the solutions.
The C-terminal region of the Robetta and QUARK models (Asn87–Leu153) superimposed onto the PfSUB1
propeptide structure with RMSD values of 7.5 Å and 3.25 Å, respectively (Figure 3).
Collectively, these approaches suggested structural similarity between PF3D7_0507400 (and its orthologues)
and subtilase propeptides, with a particularly close structural relationship to the SUB1 propeptide. Because of
this similarity, further supported by evidence presented below, the PF3D7_0507400 gene product is henceforth
referred to as SUB1-ProM (SUB1 propeptide mimic).
Figure 2. The PF3D7_0507400 gene encodes a conserved subtilisin propeptide-like protein.
(a) Multiple alignment (performed using ESPript 3.0; http://espript.ibcp.fr) [63] of the predicted primary amino acid sequences of PF3D7_0507400
(SUB1-ProM) and several Plasmodium orthologues. N-terminal secretory signal sequences predicted by SignalP 4.1 [64] are underlined. Blue boxes
indicate positions of >70% similarity (also shown in red text) or identity (white text on red shading) (see also Supplementary Figure S1). Predicted
secondary structure elements are indicated. Note that whilst the current PlasmoDB annotations suggest that some of the PF3D7_0507400
orthologues contain introns, our analysis suggests that this is incorrect, and the predicted translation products used for this analysis are based on
each gene comprising just a single exon. Plasmodium species and strains acronyms are: PF3D7, P. falciparum (3D7); PGSY75, P. gaboni; PFIT, P.
falciparum (IT); PRCDC, P. reichenowi (CDC); PCHAS, P. chabaudi chabaudi; PY17X, P. yoelii (17X); PBANCA, P. berghei (ANKA); PKNH, P.
knowlesi (H); PKNOH, P. knowlesi (Malayan Strain Pk1 A); PVX, P. vivax (Sal-1); PcyM, P. cynomolgi (M); PCYB, P. cynomolgi (B); PGAL8A, P.
gallinaceum (8A); PRELSG, P. relictum (SGS1-like); PocGH01, P. ovale curtisi (GH01). (b) Cartoon representation of the PfSUB1 propeptide core
Prodp9 (orange), shown in isolation from the PfSUB1-Fab complex X-ray crystal structure (PDB ID: 4LVN). Below, two models of the
PF3D7_0507400 gene product (called SUB1-ProM; see main text), also depicted as cartoons. The ﬁrst model (violet; Val63–Leu153) was generated
with pGenTHREADER/Modeller, whilst the second (Teal blue; Asn77–Leu153) was from I-Tasser. Right, superimposition of the three cartoons to
show spatial agreement. N- and C-termini of each modelled protein are indicated. Superimposition of the Modeller and I-Tasser models with 4LVN
showed a deviation of 0.49 Å and 1.07 Å, respectively (RMSD value on Cα).
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SUB1-ProM is expressed in asexual blood stages of P. falciparum
The transcriptional proﬁle of the P. falciparum SUB1-ProM gene obtained from previous global transcriptome
studies e.g. [46,47] (data available in PlasmoDB) indicated that PF3D7_0507400 is transcribed in asexual blood
stages, with peak expression in mature schizonts. To evaluate expression at the protein level we examined a
recently obtained global proteomic dataset [48]. This clearly identiﬁed with high conﬁdence two tryptic peptides
of SUB1-ProM (corresponding to 17.6% coverage) in extracts of P. falciparum asexual blood stage schizonts
(Supplementary Figure S3), conﬁrming that the protein is expressed in these clinically relevant developmental
stages of the parasite lifecycle.
The presence of a predicted secretory signal peptide in the SUB1-ProM sequence (and the absence of apparent
membrane-binding structures) is consistent with the protein being directed to the PV, since this is the default loca-
tion for soluble secreted proteins in the malaria parasite [49]. To experimentally investigate the expression and sub-
cellular localisation of SUB1-ProM, we expressed recombinant SUB1-ProM in Escherichia coli as a glutathione
S-transferase (GST) fusion protein (called GST-rSUB1-ProM) and raised polyclonal antibodies to the puriﬁed
protein. Analysis of parasite extracts by Western blot with these antibodies failed to detect a speciﬁc signal.
However, use of the antibodies to probe ﬁxed and permeabilized P. falciparum schizonts in indirect immunoﬂuores-
cence assays (IFA) (Figure 4 and Supplementary Figure S4) produced a signal typical of a PV or merozoite surface
location, overlapping with the established PV marker SERA5 (which is also a major endogenous substrate of
PfSUB1 [19]) and with the merozoite surface protein MSP4. Distinguishing between a merozoite surface and PV
localisation by light microscopy in Plasmodium blood stages is challenging, but given the predicted soluble nature of
SUB1-ProM it was concluded that SUB1-ProM is likely expressed in the PV or at the merozoite surface periphery.
Key structural features of SUB1 Prodp9 are conserved in SUB1-ProM
In the light of the structure-based comparisons identifying the PfSUB1 prodomain Prodp9 as the best template for
SUB1-ProM, we further examined the predicted structural similarities between these proteins. Like other subtilisins,
immediately following cleavage at the propeptide-catalytic domain junction, the propeptides of PfSUB1 and
A B C
Figure 3. Ab initio structure prediction of PF3D7_0507400 (SUB1-ProM) indicates structural similarity to the PfSUB1
propeptide.
(a) Cartoon representation of the PfSUB1 propeptide core Prodp9 (orange), shown in isolation from the PfSUB1-Fab complex
X-ray crystal structure (PDB 4LVN). (b) Top, cartoon representation of (a) superimposed onto the ab initio predicted model of
SUB1-ProM (Asn87–Leu153) from QUARK (olive green). Below, the QUARK ab initio model is shown in isolation. (c) Cartoon
representation of (a) superimposed onto the ab initio predicted model of SUB1-ProM (Asn87–Leu153) from Robetta (yellow).
Below, the Rosetta ab initio model is shown in isolation. N- and C-termini of each modelled protein are indicated.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).532
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PvSUB1 remain tightly bound to their cognate catalytic domain, primarily through interactions between the beta
sheet of the propeptide and two prominent surface-located parallel alpha helices of the catalytic domain [14,41]. In
the case of PfSUB1, key contributions to propeptide binding include hydrophobic interactions with the sidechain
of Ile178, located at the beta hairpin turn linking two strands of the Prodp9 beta sheet, which plugs into a hydro-
phobic pocket on the catalytic domain surface (Figure 5a and Supplementary Figure S5a). Interestingly, Prodp9
Ile178 is replaced by a Leu residue (Leu115) in SUB1-ProM, the sidechain of which could be accommodated in the
PfSUB1 catalytic domain hydrophobic pocket in a very similar manner; this residue is also highly conserved in the
Plasmodium SUB1-ProM orthologues, being replaced by a Val or Ile in only two cases (Figure 2a). On the opposite
side of the Prodp9-SUB1 catalytic domain interface, the sidechains of Prodp9 residues Glu209 and Asp211 engage
in H-bond interactions with main chain and sidechain atoms at the ends of the long helices on the catalytic
domain, capping these helices (Figure 5b and Supplementary Figure S5b). Similar helix-capping interactions have
been observed in other subtilisin-propeptide complexes, including that of bacterial subtilisin BPN’ where propep-
tide residues Glu69 and Asp71 perform this capping function [43,50]. The equivalent residues in SUB1-ProM,
Glu146 and Asn148, could potentially engage in similar helix-capping H-bond interactions, in agreement with the
predicted propeptide-like structure of SUB1-ProM (Figure 5b); notably, Glu146 is completely conserved in all
Plasmodium SUB1-ProM orthologues, whilst Asn148 is replaced by an Asp in some orthologues (Figure 2a).
Known subtilisin propeptide-catalytic domain interactions are further reinforced by extension of the C-terminal tail
of the propeptide into the active site groove of the catalytic domain, interacting with the non-prime side pockets in
an extended, substrate-like manner e.g. [14,41,43,51]. In the case of PfSUB1, the C-terminal tail of the propeptide
enhances its inhibitory afﬁnity but importantly is not essential for inhibition [52]. Our modelling exercise suggests
that SUB1-ProM possesses a similar C-terminal extension (Figure 5b). This does not completely mimic the Prodp9
tail, which completely ﬁlls the non-prime side (S4–S1) substrate-binding pockets due to it being derived from
autocatalytic cleavage of the precursor zymogen [14]. However, the SUB1-ProM C-terminus shares features with
the Prodp9 tail, including the presence of a Val residue (Val151) which can be modelled into the important and
relatively deep S4 binding pocket of the PfSUB1 catalytic domain [14].
It was concluded that SUB1-ProM constitutes a malarial subtilisin propeptide-like protein that is highly con-
served across the genus and that has particularly close structural relatedness to the SUB1 propeptide.
SUB1-ProM is a rapid, potent and selective inhibitor of PfSUB1 peptidase
activity
As mentioned in the Introduction, a recently characterised example of a stand-alone subtilisin propeptide-like
protein is TgMIC5 of the parasitic protist T. gondii, an organism closely related to Plasmodium. TgMIC5 regulates
Figure 4. SUB1-ProM is expressed in the PV or at the merozoite surface in P. falciparum schizonts.
IFA of mature P. falciparum 3D7 schizonts probed with the indicated antibodies. The merged images are presented both with
and without the nuclear stain DAPI. The anti-SERA5 pattern is typical of a PV location, whilst the merozoite surface protein
MSP4 delineates the plasma membrane of intracellular segmented merozoites. Note that the distance between the merozoite
plasma membrane and PV membrane is generally too small to be resolved by light microscopy. Both signals show extensive
co-localisation with the SUB1-ProM signal, which is more evident with the anti-MSP4 signal. Scale bar, 5 mm.
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the activity of a T. gondii subtilase called TgSUB1, that cleaves parasite surface proteins involved in motility and
host cell invasion [8]. TgSUB1 is not strictly a functional homologue of Plasmodium SUB1, since TgSUB1 has no
known role in egress of T. gondii from host cells. However, these observations along with our localisation of
SUB1-ProM to the PV where it could potentially interact with discharged PfSUB1, prompted us to examine the
possibility that SUB1-ProM might act similarly to TgMIC5 and inhibit the activity of endogenous PfSUB1.
To do this, we took advantage of the E. coli-derived GST-rSUB1-ProM. Cleavage of this protein at an intern-
ally engineered cleavage site allowed the production of highly puriﬁed rSUB1-ProM lacking the GST fusion
partner and the predicted signal peptide. This protein, which was fully soluble, migrated on SDS–PAGE as a
closely spaced doublet, indicating heterogeneity (Figure 6a). N-terminal sequencing by Edman degradation
showed that this was due to limited N-terminal truncation of a fraction of the protein during puriﬁcation. The
polyclonal antibodies generated against the GST-rSUB1-ProM fusion protein recognised both species as
expected (Figure 6a). Examination of the recombinant protein by CD (Figure 6b) revealed a secondary structure
content fully in accord with the predicted subtilisin propeptide-like fold. However, exhaustive attempts to
conﬁrm this by X-ray crystallography failed to obtain diffracting crystals of either GST-rSUB1-ProM or the
cleaved, GST-free form of the protein.
Figure 5. SUB1-ProM shares conserved features of the PfSUB1 propeptide required for interaction with the PfSUB1
catalytic domain.
(a) Superimposition of the pGenTHREADER/Modeller SUB1-ProM model (violet cartoon) onto the X-ray crystal structure of
PfSUB1 Prodp9 (orange) complexed to the PfSUB1 catalytic domain (grey molecular surface) (PDB ID: 4LVN). This view faces
the back of the active site in order to illustrate a structurally conserved hydrophobic plug involving Prodp9 Ile178/SUB1-ProM
Leu115 which inserts into a hydrophobic pocket in the PfSUB1 catalytic domain. (b) Rotation of the previous view to face the
active site groove, illustrating conservation of the helix capping residues Glu209/Asp211 in Prodp9 and Glu146/Asn148 in
SUB1-ProM. Hydrogen bond interactions with the PfSUB1 catalytic core are indicated (yellow dotted lines). The extreme
C-terminal residues of Prodp9 (Asp217) and SUB1-ProM (Leu153) are shown extending into the active site. The side chains of
the positionally conserved P4 Val (Prodp9 Val214 and SUB1-ProM Val151) are shown as sticks within their dotted surface area,
ﬁlling the S4 pocket of the PfSUB1 active site cleft. Note that the SUB1-ProM C-terminal tail is one residue shorter than the
Prodp9 tail and does not fulﬁl the canonical PfSUB1 active site S2 pocket requirements (Gly or Ala only), indicating a possible
non-canonical active site interaction with the PfSUB1 catalytic domain. The SUB1-ProM capping residues (Glu 146, Asn 148)
and the SUB1-ProM hydrophobic plug (Leu118) were also structurally conserved as compared with the PfSUB1 propeptide
structure 4LVN in both the Robetta and QUARK models of SUB1-ProM.
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Figure 6. SUB1-ProM is a potent, fast-binding inhibitor of PfSUB1 but not of PfSUB2.
(a) Left: Coomassie-stained SDS–PAGE analysis of puriﬁed P. falciparum rSUB1-ProM. Indicated below are the N-terminal sequences of the two
components of the doublet (arrowed) as determined by Edman degradation. The faster migrating species lacked the N-terminal 13 residues of the
higher molecular mass form, indicating limited N-terminal truncation during puriﬁcation. Right: Western blot, showing reactivity of a pool of mouse
antisera raised against puriﬁed GST-rSUB1-ProM. (b) Far-UV CD spectrum of rSUB1-ProM in solution at room temperature, indicating that the
protein is folded with an alpha/beta secondary structure consistent with that predicted by modelling (e.g. the I-Tasser full-length model predicts
41% alpha, 13% beta and 46% turn plus random coil). (c) Inhibition of rPfSUB1 activity by rSUB1-ProM. A solution of ﬂuorogenic substrate
SERA4st1F-6R12 (0.1 mM) in 25 mM Tris–HCl pH 8.2, 25 mM CHAPS, 12 mM CaCl2 was supplemented with rPfSUB1 (0.045 U in 100 ml) and the
resulting ﬂuorescence increase monitored over the ensuing 15–18 min. At this time, 1 ml of serially diluted rSUB1-ProM was added with rapid mixing
(arrowed) and the hydrolysis rate measured for a further 20 min. Reaction velocities prior to and following rSUB1-ProM addition were measured and
the Ki(app) calculated as indicated (in the typical experiment shown here the calculated value was 5.34 nM). The experiment was repeated ﬁve times,
resulting in a mean experimentally determined Ki(app) of 5.67 ± 0.25 nM. (d) rSUB1-ProM has no effect on P. falciparum SUB2 activity. Western blot
analysis of SUB2-mediated shedding of MSP1 from naturally released P. falciparum merozoites. Merozoite release was allowed to take place in the
presence of 10 mM EDTA (positive control inhibitor) or 4.95 mM rSUB1-ProM. Culture supernatants containing shed MSP1 fragments were then
analysed by Western blot, probing with two different monoclonal antibodies (89.1 or X509) that recognise either an 83 kDa shed fragment or a
33 kDa shed fragment. Whilst EDTA strongly inhibited shedding as expected, rSUB1-ProM had no discernible effect on MSP1 shedding.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 535
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To examine the capacity of SUB1-ProM to inhibit PfSUB1 enzyme activity, we used a previously described
kinetic approach [52] in which varying amounts of rSUB1-ProM were added to ongoing hydrolysis reactions
containing recombinant PfSUB1 (rPfSUB1) in the presence of a well-characterised ﬂuorogenic peptide substrate
based on a cleavage site within the endogenous protein substrate SERA4 [19]. This method enables the calcula-
tion of apparent Ki values (Ki(app)) based on the change in reaction velocity upon test inhibitor addition. As
shown in Figure 6c, the addition of rSUB1-ProM resulted in rapid, concentration-dependent decreases in
hydrolysis rate, with no evidence of a hyperbolic transition period, indicating that rSUB1-ProM is a rapid, com-
petitive inhibitor of PfSUB1. Based on the kinetic data we calculated a Ki(app) of 5.67 ± 0.25 nM, which is very
close to the previously determined value of 5.3 ± 0.4 nM for the PfSUB1 propeptide [52]. These results conﬁrmed
rSUB1-ProM as a potent, fast-binding inhibitor of PfSUB1.
Aside from PfSUB1, the only other subtilase that has been shown to play an important role in the asexual
blood stage lifecycle of P. falciparum is PfSUB2, which sheds merozoite surface proteins during RBC invasion
in a calcium-dependent manner [10]. PfSUB2 has not been expressed in an enzymatically active recombinant
form, but its activity can readily be measured in vitro by the shedding of its native parasite protein substrates
from the surface of free merozoites [10,53]. These substrates include merozoite surface protein-1 (MSP1), an
abundant glycolipid-anchored merozoite surface protein. To examine the capacity of SUB1-ProM to modulate
PfSUB2 activity, we used a simple cell-based assay in which merozoite egress and subsequent MSP1 shedding
was allowed to take place directly into medium containing rSUB1-ProM. As shown in Figure 6d, even high
concentrations of rSUB1-ProM had no discernible effect on the efﬁciency of MSP1 shedding, whereas the
calcium chelating agent EDTA displayed the expected potent inhibition. These results suggested that
SUB1-ProM does not inhibit PfSUB2 activity. It is worth noting that we have previously shown that whilst the
PfSUB2 propeptide efﬁciently inhibits PfSUB2-mediated MSP1 shedding, it does not inhibit PfSUB1 [10].
To further assess the selectivity of rSUB1-ProM, we examined its capacity to inhibit the activity of subtilisin
Carlsberg from Bacillus licheniformis, as well as pronase, which consists of a mixture of bacterial endo- and
exo-peptidases. No inhibition of any of these proteases was detected even at the highest concentrations tested
(Supplementary Figure S6). Collectively, these data suggested that SUB1-ProM is a highly selective inhibitor
of SUB1.
The SUB1-ProM capping residues and C-terminal segment are not required
for parasite growth
Recent genome-wide screens of gene essentiality in Plasmodium spp. have indicated that SUB1-ProM is dis-
pensable for parasite proliferation in vitro [54,55]. However, given the ubiquitous requirement for tight regula-
tion of the proteolytic activity of subtilisins, we sought to assess the inﬂuence of the SUB1-ProM capping and
C-terminal residues on parasite growth through a direct comparison of transgenic parasite lines expressing
wild-type or C-terminally truncated forms of SUB1-ProM. Conditional genetic recombination was used trun-
cate SUB1-ProM in in vitro cultured P. falciparum parasites, such that they lacked sequence encoding the
SUB1-ProM C-terminus (Supplementary Figure S7a), including the capping residues and Val151. In an analysis
of multiple independent clones (Supplementary Figure S7b), we found that conditional truncation of the
C-terminus of SUB1-ProM had no effect on parasite growth rates (Supplementary Figure S7c).
Discussion
It has been widely noted as remarkable that, despite their conserved core fold, subtilisin propeptides generally
share little primary sequence homology. The PfSUB1 propeptide and SUB1-ProM described here provide excel-
lent examples of that. Notwithstanding their low sequence similarity, our comparison of the modelled
SUB1-ProM structure and its other Plasmodium orthologues with the known structure of Prodp9 revealed con-
servation of speciﬁc features known to be critical for the interaction between the PfSUB1 propeptide and its
cognate catalytic domain. The structural modelling was strongly supported by our experimental results showing
unambiguously that SUB1-ProM is a potent and selective inhibitor of PfSUB1 enzyme activity, whilst our mass
spectrometric and localisation data implicated SUB1-ProM as a PV protein in asexual blood stage schizonts.
The gene encoding SUB1-ProM lies within, and is in the same orientation as, an array of three of the four
Plasmodium SUB genes, in a conﬁguration reminiscent of an operon structure. The vast majority of eukaryotic
genomes lack the operon architecture of prokaryotes, in which functionally related genes are clustered and
co-transcribed. Nonetheless, some studies have detected a tendency for functionally related eukaryotic genes to
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cluster on chromosomes, perhaps in order to fulﬁl a requirement for transcriptional co-regulation e.g. [56].
With this in mind, the chromosomal proximity of PF3D7_0507400 to the adjacent three subtilisin (or
subtilisin-like) P. falciparum genes, and the high degree of synteny across Plasmodium genomes at this locus, is
intriguing. It is tempting to speculate that the close linkage between the SUB1 and SUB1-ProM genes is indica-
tive of a need for closely synchronised expression of both genes, consistent with a functional association.
It is interesting to speculate on the physiological role SUB1-ProM might play in the parasite. The malaria
parasite replicates by an unusual process termed schizogony, in which repeated rounds of nuclear division gen-
erates a multinucleated schizont bounded by a single plasma membrane. The various intracellular organelles
are then segregated along with invagination of the plasma membrane (a process often referred to as segmenta-
tion) to produce individual mature merozoites. Premature triggering of egress could therefore result in the
release of improperly segmented - and thus non-invasive - merozoites. Indeed, experimental treatment of
mature schizonts with phosphodiesterase inhibitors, which artiﬁcially induce PfSUB1 discharge by
up-regulation of parasite cGMP levels, results in the massive premature release of largely non-invasive mero-
zoites [57,58]. There is therefore a clear biological necessity for the temporally very tightly regulated nature of
egress. It could be envisaged that mechanisms to suppress spurious, untimely low-level SUB1 activity in the PV
(e.g. due to ‘leaky’ premature exoneme discharge) might be important to prevent potentially catastrophic pre-
mature activation of the egress pathway. We propose that SUB1-ProM may play such a regulatory role in the
PV or at the intracellular merozoite surface (which is effectively exposed to the contents of the PV lumen).
This would be by no means unprecedented; endogenous protease inhibitors are widespread in biological
systems, where they often play crucial roles, and although protein-based peptidase inhibitors are relatively
sparse in prokaryotes and unicellular eukaryotes [59], they have previously been identiﬁed in the malaria
parasite for other peptidase classes [60–62]. Our ﬁnding that the PfSUB1 and PvSUB1 propeptides were
the best templates for homology modelling of SUB1-ProM may indicate an evolutionary adaptation of
SUB1-ProM to optimally mimic these propeptides in order to perform its regulatory function. In apparent con-
ﬂict with this notion is the structure of the C-terminal tail of SUB1-ProM, which contains conserved residues
involved in interactions with SUB1, but which varies in length in different orthologues and which does not
appear to completely ﬁll the active site groove when modelled in complex with PfSUB1. Our own previous
studies have shown that the C-terminal tail of the PfSUB1 propeptide is not essential for inhibition [52], and
comparative analysis of several Plasmodium SUB1 orthologues have indicated subtle differences in their sub-
strate speciﬁcity [30]. Collectively, this may explain the observed variation in the C-terminal tail sequences of
the SUB1-ProM orthologues, each of which may be optimally adapted to its cognate SUB1 orthologue. It may
be critical that SUB1-ProM is not too potent an inhibitor, since its proper functioning may require a ﬁne
balance between efﬁcient inhibition of low-level, premature SUB1 activity in the PV yet without blocking even-
tual egress.
We observed no effect of truncation of the SUB1-ProM C-terminus on parasite growth in vitro. Combined
with existing data from global evaluations of gene essentiality in Plasmodium [54,55], these results suggest that
any contribution of SUB1-ProM to overall parasite ﬁtness may be relatively subtle, or that any essential func-
tions of SUB1-ProM do not require the C-terminal region of the protein. Given that SUB1 is responsible
for the maturation of a range of merozoite antigens prior to exposure of the merozoite to the host immune
system, it will be important to establish the importance of SUB1 regulation by SUB1-ProM in the presence of
physiological selective pressures.
In conclusion, we have identiﬁed a putative endogenous inhibitor of the essential egress-related protease
SUB1, expanding our understanding of the mechanisms underlying subtilase function in this important
intracellular pathogen.
Key points
• Malaria parasites use a subtilisin-like protease, SUB1, to egress from red cells
• We identify a stand-alone malarial subtilisin propeptide-like protein, SUB1-ProM
• SUB1-ProM is likely expressed in the lumen of the parasitophorous vacuole
• SUB1-ProM is a potent, selective inhibitor of SUB1
• SUB1-ProM may be an endogenous regulator of SUB1 that prevents premature egress
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